Industry News

Boehringer Ingelheim's OFEV Approved by FDA as a Kinase Inhibitor to Treat Idiopathic Pulmonary Fibrosis
Shire eyes deals using $1.6bn AbbVie windfall
FDA OKs Eylea (aflibercept) Injection
Gay-rights group backs use of HIV-prevention pill
Direct Flow Medical Gets CE Mark for Transfemoral Aortic Heart Valve Delivery System
FDA Approves B. Braun Injection Containers
Chimerix gets FDA OK to test drug for Ebola
Chimerix gets FDA OK to test drug for Ebola
FDA Approves Labeling With Abuse-Deterrent Features For Third Extended-Release Opioid Analgesic
BRIEF: HHS helps fund development of new Ebola vaccine
OctreoPharm Sciences Gets FDA Orphan Drug Designation for Management of Neuroendocrine Tumors
Bayes Impact Uses Ayasdi's Advanced Analytics to Discover New Breakthroughs in Parkinson's Disease Ayasdi Cure Precisely Stratifies Patients to Improve Outcomes, Using Data From Smartphones and Clinical Research
ISPE Plan to Prevent Drug Shortages released at Annual Meeting Experts team-up to help keep quality medicines available to those who need them
ISPE Plan to Prevent Drug Shortages released at Annual Meeting Experts team-up to help keep quality medicines available to those who need them
Breckenridge Pharmaceutical, Inc. Announces Approval of Mefenamic Acid Capsules, USP 250mg
FDA weighs removing bolded warning from Chantix
FDA Grants Approval to Velcade (bortezomib)
Breckenridge Pharmaceutical, Inc. Announces Approval of Mefenamic Acid Capsules, USP 250mg
FDA weighs removing bolded warning from Chantix
FDA Grants Approval to Velcade (bortezomib)
Sun Life Financial sheds light on factors and costs of not taking medications correctly
Pharmatech Hires Richard Aleman to Lead Regulatory Compliance
AbbVie Reports Late-Breaking Results from Phase 3 Trial of HUMIRA, Has Met Primary Endpoint in PIONEER II
Nuvilex Applies to FDA for Orphan Drug Designation for Its Cell-in-a-Box(R) Treatment for Pancreatic Cancer
Pfizer Announces FDA Acceptance Of Palbociclib New Drug Application With Priority Review